FdaApplication

ANDA 213708

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2024-11-20

Products (1)

ProductActive ingredientStrengthDosage form
EPINEPHRINEEPINEPHRINE1MG/ML (1MG/ML)SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS

1 product